Get started
Author

Heather S. Scott

Observed name: Heather Scott
ORCID: 0000-0001-6936-9330
Observed ORCID: 0000-0001-6936-9330
OpenAlex ID: A5008334850
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer
2022 · Gemma E. Mudd, Heather Scott, et al. · Journal of Medicinal Chemistry · 114
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2022 · Michael Rigby, Gavin Bennett, et al. · Molecular Cancer Therapeutics · 88
Structure-Guided Chemical Optimization of Bicyclic Peptide (Bicycle) Inhibitors of Angiotensin-Converting Enzyme 2
2023 · Maximilian A. J. Harman, Steven J. Stanway, et al. · Journal of Medicinal Chemistry · 13
Abstract 5807: Bicycle Toxin Conjugates®for the treatment of solid tumors
2024 · Stephen J. Walsh, Johanna Lahdenranta, et al. · Cancer Research · 2
1124 Discovery and evaluation of bicyclic peptides as modulators of pattern recognition receptors
2023 · Laura L Goodfield, Robert P Hammer, et al. · Journal for ImmunoTherapy of Cancer
PDF
Supplementary Data from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
PDF
Supplementary Data from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
PDF
Supplementary Figure from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
PDF
Supplementary Figure from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
Supplementary Data from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
Data from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
Data from BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
2023 · Michael Rigby, Gavin Bennett, et al.
Abstract 4233: Generation of a Bicycle NK-TICA™, a novel NK cell engaging molecule designed to induce targeted tumor cytotoxicity
2022 · Fay J. Dufort, Christopher J. Leitheiser, et al. · Cancer Research
Abstract 4230: Modeling the cDC1 ex vivo and in vitro: Development and comparison of a conventional dendritic cell culture system for industry
2022 · Laura L. Goodfield, Johanna Lahdenranta, et al. · Cancer Research
Works count: 14
Citation count: 217
H-index: 3
I10-index: 3
Year
Topic
Type